Cannabis Co. Cresco Lab's Q2 Gross Profit Increases Over 9% YoY, Reports Nearly 7% Drop In Revenue
Cannabis Co. Cresco Lab's Q2 Gross Profit Increases Over 9% YoY, Reports Nearly 7% Drop In Revenue
The company continues to hold the No. 1 share position in Illinois, Pennsylvania and Massachusetts.Cannabis producer and operator of Sunnyside dispensaries, Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) released its financial and operating results Thursday for the second quarter ended June 30, 2024.
大麻生產商和Sunnyside藥房運營商Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ)於2024年6月30日結束的第二季度公佈了其財務和營運結果。
"Our Q2 results demonstrate the sustainability of the improvements we've made to the business over the past year with $184 million in revenue at a 29% Adjusted EBITDA margin," said CEO Charles Bachtell. "It is clear our strategy is working; we are creating the brands consumers love and delivering best-in-class retail operations through Sunnyside."
首席執行官查爾斯·巴切爾說：「我們第二季度的結果表明，我們在過去一年中對業務所做的改進是可持續的，我們的營業收入爲$18400萬，我們的經調整EBITDA利潤率爲29%。顯然我們的策略是奏效的；我們正在打造消費者喜愛的品牌，並通過Sunnyside提供最佳的零售業務。」
Read Also: Paying Dues For Nothing? Cannabis Workers At Cresco Labs' Illinois Facility Leave The Union, Get 15% Raises
閱讀詳情：付出的代價是否無用？ Cresco Labs伊利諾伊州工廠的大麻工人放棄工會，獲得15％的加薪。
Q2 2024 Financial Highlights
2024年第二季度財務業績亮點
- Net revenues totaled $184.3 million, down from $197.9 million in the prior year's period.
- Gross profit totaled $94.8 million, up from $86.7 million in the same period last year.
- Gross profit margin was 51.4%, up from 43.8% in the second quarter of fiscal 2023.
- Operating income was $32.4 million, compared to a $10.7 million loss from operations in the same period of fiscal 2024.
- Net loss totaled $51.2 million, up from $43.5 million net loss in the prior year's period.
- Adjusted EBITDA (a non-GAAP measure) came in positive at $53.9 million, compared to an adjusted EBITDA gain of $40.5 million in the corresponding quarter of last year.
- Second quarter operating cash flow of $17 million and free cash flow of $11 million.
- 淨收入總計爲$18430萬，低於去年同期的$19790萬。
- 毛利潤總計爲$9480萬，高於去年同期的$8670萬。
- 毛利潤率達到51.4％，高於2023財年第二季度的43.8％。
- 營業收入爲$3240萬，而去年同期虧損$1070萬。
- 淨虧損爲$5120萬，高於去年同期的$4350萬。
- 調整後的EBITDA（非普通會計原則指標）爲正$5390萬，而去年同期調整後的EBITDA收益爲$4050萬。
- 第二季度的經營現金流爲$1700萬，自由現金流爲$1100萬。
The company continues to hold the No. 1 share position in Illinois, Pennsylvania and Massachusetts.
該公司繼續持有伊利諾伊州，賓夕法尼亞州和馬薩諸塞州的第一份市場份額。
"So far this year we've generated over twice as much operating cash flow than the first half of last year and we are putting it to work strengthening our balance sheet, investing in our core growth states with adult-use optionality, and exploring accretive, incremental M&A and other business opportunities," Bachtell continued.
巴切爾繼續說：「今年迄今爲止，我們產生的經營現金流是去年上半年的兩倍以上，我們正在利用它來加強我們的資產負債表，投資於我們的核心增長州成爲成人使用的選擇，並探索增值、漸進式的併購和其他業務機會。」
- $65.6M Equity Offering Led By Good Day Farm Signals M&A Activity – What's The Big Picture?
- Good Day Farm領導的6560萬美元股權發行預示着併購活動-大局觀如何？
CRLBF Price Action
CRLBF股票價格走勢
Cresco's shares traded 2.80% higher at $1.48 per share at the time of publishing late morning on Thursday.
發表時週四上午晚些時候，Cresco的股票交易價每股1.48美元，上漲2.80％。
譯文內容由第三人軟體翻譯。
